BioCentury | Feb 9, 2018
Product R&D

Debugging the microbiome

...resistance to marketed therapies. Three of them -- AmpliPhi Biosciences Corp., Pherecydes Pharma S.A. and Phico Therapeutics Ltd....
...of Medicine, Tokyo, Japan Massachusetts Institute of Technology, Cambridge, Mass. Pherecydes Pharma S.A., Romainville, France Phico Therapeutics Ltd....
BioCentury | Aug 3, 2017
Strategy

FDA's phage philosophy

...Targets ASPH (HAAH) - aspartate β-hydroxylase Mark Zipkin, Staff Writer AmpliPhi Biosciences Corp. National Institutes of Health Panacea Pharmaceuticals Inc. Phico Therapeutics Ltd. Texas...
BioCentury | Sep 24, 2012
Clinical News

Phico preclinical data

...Data were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco. Phico Therapeutics Ltd....
BioCentury | Jun 13, 2011
Financial News

Phico completes venture financing

Phico Therapeutics Ltd. , Cambridge, U.K. Business: Infectious Date completed: 6/3/11 Type: Venture financing Raised: £1 million ($1.6 million) Investors: Company directors WIR Staff Infectious...
BioCentury | Nov 1, 2010
Company News

Phico board of directors update

Phico Therapeutics Ltd. , Babraham, U.K. Business: Infectious Appointed: Anthony Martin as non-executive chairman, formerly chairman at Molecular Insight Pharmaceuticals Inc. ; he replaces Flic Gabbay WIR Staff...
BioCentury | Jun 28, 2010
Clinical News

PT1: Phase I data

...presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy meeting in Boston in September. Phico Therapeutics Ltd....
BioCentury | Apr 28, 2008
Clinical News

Phico preclinical data

...and gene expression. The company plans to start a clinical trial of PT1.2 in 4Q08. Phico Therapeutics Ltd....
Items per page:
1 - 7 of 7
BioCentury | Feb 9, 2018
Product R&D

Debugging the microbiome

...resistance to marketed therapies. Three of them -- AmpliPhi Biosciences Corp., Pherecydes Pharma S.A. and Phico Therapeutics Ltd....
...of Medicine, Tokyo, Japan Massachusetts Institute of Technology, Cambridge, Mass. Pherecydes Pharma S.A., Romainville, France Phico Therapeutics Ltd....
BioCentury | Aug 3, 2017
Strategy

FDA's phage philosophy

...Targets ASPH (HAAH) - aspartate β-hydroxylase Mark Zipkin, Staff Writer AmpliPhi Biosciences Corp. National Institutes of Health Panacea Pharmaceuticals Inc. Phico Therapeutics Ltd. Texas...
BioCentury | Sep 24, 2012
Clinical News

Phico preclinical data

...Data were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco. Phico Therapeutics Ltd....
BioCentury | Jun 13, 2011
Financial News

Phico completes venture financing

Phico Therapeutics Ltd. , Cambridge, U.K. Business: Infectious Date completed: 6/3/11 Type: Venture financing Raised: £1 million ($1.6 million) Investors: Company directors WIR Staff Infectious...
BioCentury | Nov 1, 2010
Company News

Phico board of directors update

Phico Therapeutics Ltd. , Babraham, U.K. Business: Infectious Appointed: Anthony Martin as non-executive chairman, formerly chairman at Molecular Insight Pharmaceuticals Inc. ; he replaces Flic Gabbay WIR Staff...
BioCentury | Jun 28, 2010
Clinical News

PT1: Phase I data

...presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy meeting in Boston in September. Phico Therapeutics Ltd....
BioCentury | Apr 28, 2008
Clinical News

Phico preclinical data

...and gene expression. The company plans to start a clinical trial of PT1.2 in 4Q08. Phico Therapeutics Ltd....
Items per page:
1 - 7 of 7